Your search returned 3 results.

Results
	1.	New challenges for HDL-modifying therapies as a strategy to lower cardiovascular disease events in statin-treated patients. MedStar authors: Brewer, H Bryan Jr PMID: 25702643 Year: 2015 Citation: Cardiovascular Drugs & Therapy. 29(1):1-3, 2015 Feb. Institution: MedStar Heart & Vascular Institute Medline publication type: Comment Editorial Form of publication: Journal Article All authors: Brewer HB Jr, Rosenson RS DOI: http://dx.doi.org/10.1007/s10557-015-6576-7 Add to cart (remove)
	2.	Novel emerging therapies in atherosclerosis targeting lipid metabolism. [Review] MedStar authors: Ghosh, Raktim K PMID: 32363959 Year: 2020 Citation: Expert Opinion on Investigational Drugs. 29(6):611-622, 2020 Jun. Institution: MedStar Union Memorial Hospital Medline publication type: Journal Article Form of publication: Journal Article All authors: Aronow WS, Bandyopadhyay D, Blumenthal C, Chatterjee S, Ghosh RK, Gupta M, Jain V, Lavie CJ, Ray KK, Virani SS DOI: https://dx.doi.org/10.1080/13543784.2020.1764937 Add to cart (remove)
	3.	Evacetrapib alone or in combination with statins lowers lipoprotein(a) and total and small LDL particle concentrations in mildly hypercholesterolemic patients. MedStar authors: Brewer, H Bryan PMID: 27206939 Year: 2016 Citation: Journal of Clinical Lipidology. 10(3):519-527.e4, 2016 May-Jun Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Brewer HB, Deeg MA, Krueger KA, Liu L, Nicholls SJ, Nissen SE, Ruotolo G, Wang MD, Willey MB DOI: https://dx.doi.org/10.1016/j.jacl.2015.11.014 Add to cart (remove)

Powered by Koha